Digostics Surpasses £500,000 Funding Milestone on Crowdcube
Digostics Surpasses £500,000 Funding Milestone on Crowdcube
NHS Hospital Trust Pilot of New Testing Technology Sees Pregnant Women in Southampton Become the First Patients Globally to Access Gestational Diabetes Testing at Home.
NHS Hospital Trust Pilot of New Testing Technology Sees Pregnant Women in Southampton Become the First Patients Globally to Access Gestational Diabetes Testing at Home.
Oxford, United Kingdom 23/07/2025 – Digostics, the UK-based health tech company behind the world’s first oral glucose intolerance test (OGTT) that can be done at home instead of a clinic or hospital, today announced it has surpassed £500,000 in funding on the Crowdcube equity crowdfunding platform, with more than 100 investors backing the company’s mission to revolutionise diabetes detection and monitoring.
GTT@home is an accurate home-use OGTT test kit developed by Digostics that uses finger-prick blood samples to measure how well the body processes glucose. The test is as accurate as lab-based OGTTs when used in adults with glucose intolerance, type 2 diabetes, or in pregnant women to diagnose gestational diabetes.
The raise builds on Digostics’ momentum across the UK and internationally, where GTT@home is already CE-marked, and approved for use in other markets. The digital platform has already delivered over 5,000 NHS tests and is being adopted by multiple NHS Trusts for gestational diabetes screening in pregnancy. The company is also driving early international interest with operations in the UAE and Singapore.
“Reaching the £500,000 threshold is an exciting moment, one that reflects investor belief in our mission to make diabetes screening simpler, earlier, and more accessible,” said James Jackson, CEO and Founder of Digostics. “With healthcare systems under increasing pressure, innovations like GTT@home can reduce clinical burden while improving patient experience and outcomes.”
"We hope this revolutionary new at-home test is going to dramatically change the way we deliver gestational diabetes testing during antenatal care."
Dr Matthew Coleman
Click the button below for more GTT@home product-specific information exploring:
• the GTT@home test kit's contents
• the novel GTT@home test device
• at-home versus in-clinic test comparisons
• patient and healthcare professional support
Click the button below for more GTT@home product-specific information exploring:
• the GTT@home test kit's contents
• the novel GTT@home test device
• at-home versus in-clinic test comparisons
• patient and healthcare professional support
About Digostics
Far too many people across the world are living with undiagnosed diabetes.
UK-based Digostics' mission is to enable healthcare providers to identify everyone with diabetes, and those at risk of developing diabetes, by eliminating the common barriers that inhibit accurate and timely testing using the gold standard oral glucose tolerance test (OGTT).
Digostics is proud to offer GTT@home - the world’s first home OGTT offering and the most accessible and scalable way for clinical teams to realise their diabetes testing objectives.
To learn more, visit www.digostics.com
About University Hospital NHS Foundation Trust
University Hospital Southampton NHS Foundation Trust provides services to some 1.9 million people living in Southampton and south Hampshire, plus specialist services such as neurosciences, cardiac services and children's intensive care to more than 3.7 million people in central southern England and the Channel Islands.
UHS is one of the largest acute teaching trusts in England with a staff of 13,000 and a turnover of more than £1bn in 2020/21.
We are one of only two major trauma centres in the South of England for both adults and children.
UHS is consistently one of the UK’s highest recruiting trusts of patients to clinical trials.
Could GTT@home be of assistance to your patients?
Please get in touch by completing the form below or calling us on +44 (0)330 113 9145.
References
¹ International Diabetes Federation - Diabetes Atlas 10th Edition 2021
² NHS Gestational Diabetes Overview
³ International Diabetes Federation - Care and Prevention - Gestational Diabetes
† Pubmed - Future risk of diabetes in mother and child after gestational diabetes mellitus 2009
Images of Matthew Coleman and of University Hospital Southampton's premises are kindly provided by University Hospital Southampton NHS Foundation Trust.